Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

Although it's not yet clear how health care providers will respond to value-based payment models, an examination of pharmaceutical industry practices can provide insights into problems that may arise — and practices to avoid. In 2015, the U.S. Department of Health and Human Services announced a...

Full description

Bibliographic Details

Published in:	The New England journal of medicine Vol. 375; no. 21; pp. 2013 - 2015
Main Authors:	Dafny, Leemore S, Ody, Christopher J, Schmitt, Matthew A
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 24.11.2016
Subjects:	Brand names Consumers Cost Sharing Discount coupons Drug Costs Drug Industry - economics Medicare - economics Pharmaceutical industry Prescription drugs Prescription Fees United States Value-Based Purchasing United States > US Virginia
ISSN:	0028-4793, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!